Ionis announces GSK has advanced bepirovirsen into Phase 3 development

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. SNOW
2. AVGO
3. RARE
4. HPE
5. FIVE
6. VRTS
7. NTAP
8. CRWD
9. CHPT
10. AHR

Go back to Ionis announces GSK has advanced bepirovirsen into Phase 3 development
(NASDAQ: IONS) Delayed: 61.33 --0 (-0%)
Previous Close $61.33    52 Week High $62.68 
Open $61.33    52 Week Low $19.59 
Day High $61.33    P/E N/A 
Day Low $61.33    EPS $0.00 
Volume 5,043